Abstract
Noninvasive cardiac imaging plays a central role in the diagnosis of coronary artery disease and cardiomyopathy, as well as in the decision making for therapeutic interventions. Proper assessment of the degree of myocardial ischemia and viability is essential to aid in therapies that may improve patient outcomes. In addition, a wealth of evidence exists on the prognostic value of the information obtained from noninvasive imaging. One must utilize an imaging study or studies in an organized fashion, incorporating the latest scientific evidence, guidelines and appropriateness criteria. This review summarizes the advantages, disadvantages and relevant literature on various imaging modalities currently available for the evaluation of myocardial ischemia and viability.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.